Image

Optimization of NIBS for Treatment of Addiction

Optimization of NIBS for Treatment of Addiction

Recruiting
18-85 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to assess the effects of transcranial Direct Current Stimulation (tDCS) applied in conjunction with Transcranial Ultrasound (TUS) for the treatment of addiction in opiate use disorder with chronic pain. The investigators hypothesize that there will be a decrease in drug use and improved psychosocial assessments with active stimulation, when compared to sham stimulation.

Eligibility

Inclusion Criteria:

  1. Providing informed consent to participate in the study.
  2. 18 to 85 years old.
  3. Having a diagnosis of OUD, in the setting of CP:
    • OUD of more than 6 months duration as defined by Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [64] and a positive urine toxicology screen.
    • or OUD patients who still feel craving or have not received more than 60 mg of methadone/day from the Methadone program.
  4. Lives in the immediate area with no plans to relocate

Exclusion Criteria:

  1. The subject is pregnant.
  2. Recently started on antiepileptic drug therapy.
  3. History of illegal stimulant use as demonstrated by urine toxicology.
  4. . Ingestion of poppy seeds or herbal teas containing Papaveris Fructus (may cause a positive opiate test for morphine, codeine [66, 67]).
  5. History of neurological disorders involving stroke, brain tumors, or epilepsy as self- reported (note patients will also be evaluated via electroencephalography (EEG) at baseline 1 week prior to stimulation and any patient showing abnormal EEG activity will be removed)).
  6. History of unexplained fainting spells as self-reported.
  7. History of head injury resulting in more than a momentary loss of consciousness as self-reported.
  8. History of brain surgery as self-reported.
  9. Contraindications to tDCS applied in conjunction with TUS:
    • Metal in the head, or
    • Implanted brain medical devices.
  10. Suffering from severe depression (with a score of >30 in the Beck Depression

    Inventory (BDI), PHQ-9≥10).

  11. Active malignancy.
  12. History of suicidal behavior or suicide attempts.

Study details
    Opioid-use Disorder
    Chronic Pain

NCT04379115

Case Western Reserve University

11 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.